Evogene to Participate in Upcoming BIO-Europe in Germany and Drug Discovery Chemistry Europe in Spain

Evogene announced it will attend BIO-Europe in Cologne, Germany (November 9-11, 2026) and present a scientific poster at Drug Discovery Chemistry Europe in Barcelona, Spain (November 10-12, 2026). At BIO-Europe, Chief Development Officer Dr. Gabi Tarcic will hold one-on-one meetings with potential partners on AI-driven small-molecule collaboration opportunities. In Barcelona, the company will showcase its ChemPass AI platform spanning virtual screening, QSAR-driven hit-to-lead, and generative de novo design.

AI-generated analysis of a public disclosure. Not investment advice; verify against the original document.